Emcure Pharmaceuticals Merger 2026: 2 Units Fold In
Emcure Pharmaceuticals merger 2026: board approves folding wholly owned Zuventus and Emcutix into the parent. No new shares; NCLT approval is needed.
Emcure Pharmaceuticals merger 2026: board approves folding wholly owned Zuventus and Emcutix into the parent. No new shares; NCLT approval is needed.